Doxorubicin vs epirubicin, report of a second-line randomized phase II/III study in advanced breast cancer. EORTC Breast Cancer Cooperative Group (Q36292899)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Doxorubicin vs epirubicin, report of a second-line randomized phase II/III study in advanced breast cancer. EORTC Breast Cancer Cooperative Group |
scientific article |
Statements
1 reference
Doxorubicin vs epirubicin, report of a second-line randomized phase II/III study in advanced breast cancer. EORTC Breast Cancer Cooperative Group (English)
1 reference
Jassem J
1 reference
Bontenbal M
1 reference
Andersson M
1 reference
Wildiers J
1 reference
Cocconi G
1 reference
Paridaens R
1 reference
Rotmensz N
1 reference
Sylvester R
1 reference
Mouridsen HT
1 reference
Klijn JG
1 reference
van Oosterom AT
1 reference
1 June 1998
1 reference
1 reference
2257-2263
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference